Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Une scientifique regarde un échantillon

Innovation at Paris Brain Institute

Reading time: 1min

The objective of the Directorate of Innovation is to bring innovations to patients by enabling and accelerating the development of innovative products or companies in the field of neurology.

The missions of Paris Brain Institute's Innovation Directorate are as follows:

  • Identify know-how and inventions with potential for industrial exploitation
  • Implement strategies for maturation and patenting
  • Developing and sustaining R&D partnerships with industrial enterprises
  • Assist researchers and clinicians in selecting the most appropriate commercialization strategy and the right industrial partner to ensure rapid transfer of results from the bench to the bedside
  • Strengthen the acceleration programme with innovation units dedicated to applied research and design, focusing on product development in a spirit of Biotech and MedTech
  • Support the creation of start-up Biotech and MedTech companies and enable their incubation in the iPEPS incubator

The ambition of the Directorate of Innovation is to bridge the gap between academic and clinical research. Academic (basic research and applied) research solutions have a low level of maturity, which needs to be increased in order to obtain solutions with a higher level of maturity that can then reach the stage of clinical research or even further their integration into the health system.
To this end, the Directorate of Innovation concentrates its efforts on increasing the level of maturity of the results of academic research by using all the levers of valorisation available within the Institute.

Innovation Units

Innovation Units

The Innovation Directorate has developed 3 specialized innovation units by technology or knowledge areas:

  • Sleeping Beauties: identification and development of new molecules (re-use of molecules or design of new molecules) to produce drug candidates that can be made available to clinicians
  • Genov: development of gene and cell therapy tools to treat rare genetic neurological diseases by exploiting discoveries made by scientific and clinical teams in the field of genetics
  • Care Lab : development of new low-tech tools and software, based on analysis of the patient's journey and the needs of patients/caregivers, using the Design thinking methodology.
Start-up studio

Start-up studio

Paris Brain Institute's Innovation Directorate has set up a studio start-up to help researchers from the Institute and elsewhere to set up their own businesses through:

  • NeurAL: a program that drives and whispers research projects to the creation of a society. NeurAL offers entrepreneurship expertise, support, and access to the Institute’s facilities and funds.
  • iPEPS incubator: this incubator focuses on start-ups from the NeurAL programme or other neurological research centres across the EU.
Business Unit

Business Unit

The Directorate of Innovation has developed a Business Unit which supports the Institute's researchers in the establishment of scientific collaborations based on:

  • Business Development: to promote the Institute's scientific and medical expertise and skills to develop collaborative research programs with industrial partners. Propose the most favourable route of valuation for patents or assets developed by the Institute through the establishment of licensing agreements and co-development strategies
  • Intellectual property: to study the patentability of research results, to ensure that patent filing criteria are met, to create favourable conditions for the secure transfer of data and biological material
  • Strategic Alliances: managing public-private consortia.

News that might interest you

Une fusée qui décolle
Paris Brain Institute launches the 2nd edition of NeurAL, its studio startup program dedicated to neuroscience
With support from the Anne and Claude Berda Foundation and from Indosuez Wealth Management, Paris Brain Institute is launching the second edition of NeurAL, its startup studio program.
07.01.2024 Research applications
Logo EBRAINS
Paris Brain Institute becomes associated member of EBRAINS AISBL
Paris Brain Institute is pleased to announce its membership to EBRAINS AISBL, a new digital research infrastructure (RI), created by the EU-funded Human Brain Project (HBP), to foster brain-related research.
10.13.2022 Research applications
Logo Wefight
Pierre Nectoux, co-founder of Wefight, named to the "30 Under 30" ranking by Forbes France magazine
Forbes France magazine unveiled in its latest issue the ranking of its fifth edition "30 Under 30". This ranking is dedicated to a new generation of entrepreneurs who disrupt the codes of their field: sports, finance, art, entertainment, environment...
04.13.2021 Research applications
Logo de Healthy Mind et Uptale
Healthy Mind and Uptale selected for STATION F's Future 40 ranking
On November 18, Station F unveiled the second edition of its Future 40 ranking. 2 startups hosted in our incubator iPEPS -The Healthtech Hub are included: Healthy Mind and Uptale.
11.18.2020 Research applications
Logo Scipio bioscience
Scipio bioscience raises €6.0 M Series A financing 
To develop and launch a kit dedicated to sample preparation for single-cell RNA-sequencing
03.20.2020 Research applications
Logo du World Economic Forum
In partnership with ICM, A joint FIA & EMOTIV tech experience leveraging Virtual Reality and real-time neuroinformatics to improve road safety will premiere in Davos next week
The World Economic Forum is held from January 23 to 26. Some 70 heads of state and government are expected to participate in this popular meeting of bosses from around the world.
01.23.2018 Research applications
See all our news